The value of F-18-fluorodeoxyglucose positron emission tomography/computed tomography in carcinoma of an unknown primary: diagnosis and follow-up

Yapar Z., KIBAR M., YAPAR A. F., PAYDAŞ S., REYHAN M., Kara O., ...Daha Fazla

NUCLEAR MEDICINE COMMUNICATIONS, cilt.31, sa.1, ss.59-66, 2010 (SCI-Expanded, Scopus) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 31 Sayı: 1
  • Basım Tarihi: 2010
  • Doi Numarası: 10.1097/mnm.0b013e328332b340
  • Dergi Adı: NUCLEAR MEDICINE COMMUNICATIONS
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.59-66
  • Anahtar Kelimeler: carcinoma of an unknown primary, diagnosis, F-18-fluorodeoxyglucose positron emission tomography/computed, tomography, prognosis, therapy response, PRIMARY SITE, CERVICAL-CARCINOMA, PRIMARY ORIGIN, PRIMARY TUMORS, DUAL-MODALITY, PRIMARY CUP, CANCER, PET/CT, MANAGEMENT, METASTASES
  • Bezmiâlem Vakıf Üniversitesi Adresli: Hayır

Özet

Background The management of the patients with carcinoma of an unknown primary represents a difficult challenge in oncology. F-18-fluorodeoxyglucose positron emission tomography/computed tomography (FDG PET/CT) has provided new insights in the diagnosis, staging, and follow-up of oncological patients.